Yeast Study Sheds Light on Progerin's Aging Impact

Researchers develop a yeast-based model to study premature aging caused by the toxic protein Progerin.

Apr. 18, 2026 at 1:44am

Got story updates? Submit your updates here. ›

A bold, abstract painting in earthy tones featuring sweeping geometric shapes, concentric circles, and precise botanical spirals, conceptually representing the intricate molecular structures and forces involved in cellular aging processes.A conceptual visualization of the complex biological mechanisms underlying cellular aging and the accumulation of the toxic Progerin protein, as revealed by a new yeast-based model study.Buffalo Today

A new study published in the journal Aging-US has used the budding yeast, Saccharomyces cerevisiae, as a model to investigate the mechanisms behind premature aging caused by the accumulation of the toxic protein Progerin. The researchers found that expressing Progerin in yeast cells led to slower growth, increased genome instability, and a significant reduction in lifespan, in contrast to the normal protein Lamin A which did not produce the same harmful effects. This yeast-based model provides a valuable platform for studying the biological drivers of premature and normal aging.

Why it matters

Understanding the molecular mechanisms behind premature aging disorders like Hutchinson–Gilford Progeria Syndrome is crucial for developing potential treatments. Yeast is an excellent model organism for aging research due to its well-characterized genetics and biochemical pathways that are highly conserved across species, making this new study an important step forward in this field.

The details

The study was led by researchers from the University of Saskatchewan and the University of Alberta, who developed a genetically engineered yeast strain to express the Progerin protein. They compared the effects of Progerin to the normal Lamin A protein, finding that Progerin accumulates in aging yeast cells and is more stable, leading to slower growth, increased genome instability, and reduced lifespan. These observations mirror what has been reported in human cells affected by Progeria, validating the use of this yeast model for further aging research.

  • The study was published on April 3, 2026 in the journal Aging-US.
  • The research paper is titled "Modeling premature aging in yeast via the expression of Progerin" and is Volume 18 of the journal.

The players

Zachery R. Belak

The first author of the study, from the University of Saskatchewan.

Troy A.A. Harkness

The corresponding author of the study, from the University of Saskatchewan and the University of Alberta.

Saccharomyces cerevisiae

The budding yeast used as the model organism in this study, which is an excellent model for aging research due to its well-characterized genetics and biochemical pathways.

Progerin

The toxic protein responsible for Hutchinson–Gilford Progeria Syndrome, which was expressed in the genetically engineered yeast cells to study its effects on aging.

Lamin A

The normal counterpart to Progerin, which was used as a control in the study to compare the effects on yeast cells.

Got photos? Submit your photos here. ›

What they’re saying

“Taken together, expression of Progerin in yeast cells mimics what is observed in human cells, establishing yeast as a powerful model to discover genetic mechanisms driving premature and normal aging.”

— Troy A.A. Harkness, Corresponding author

What’s next

The researchers plan to use this yeast-based model to further investigate the specific genetic and biochemical pathways impacted by Progerin accumulation, with the goal of identifying potential therapeutic targets for premature aging disorders.

The takeaway

This new yeast model provides a valuable platform for studying the molecular mechanisms underlying premature aging disorders like Progeria, as well as normal aging processes. By leveraging the well-characterized biology of yeast, the researchers have established an efficient system to test interventions aimed at reducing toxic protein accumulation and improving cellular health during aging.